{
    "clinical_study": {
        "@rank": "105786", 
        "acronym": "Pascal", 
        "arm_group": [
            {
                "arm_group_label": "A session", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Four sessions", 
                "arm_group_type": "Other", 
                "description": "Every session are spaced out of month"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to show that PRPC performed in a single session using a Pascal\n      laser leads to better management of the disease (better rate of regression of neovessels,\n      lower risk of a loss of visual acuity in the  long term related to macular edema), a saving\n      of time and better comfort for both patient and doctor."
        }, 
        "brief_title": "Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients.", 
        "condition": "Diabetes Type 1 or 2 With Diabetic Retinopathy.", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus, Type 1", 
                "Diabetic Retinopathy", 
                "Macular Edema", 
                "Retinal Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diabetes type 1 or 2\n\n          -  Subjects with severe non-proliferative or early proliferative diabetic retinopathy\n             (according to the Alfediam classification)\n\n          -  Subjects with central macular thickness less than or equal to 350 \u00b5m according to\n             spetralis OCT\n\n          -  Subjects registered with a social security agency\n\n          -  Subjects who have provided written informed consent\n\n          -  Subjects aged 18 or above\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Breastfeeding women\n\n          -  Patients presenting a contra-indication to Mydriaticum and Neosynephrine\n\n          -  History of glaucoma or non-controlled ocular hypertension\n\n          -  Blindness in one eye\n\n          -  History of renal insufficiency requiring dialysis, or kidney or pancreas\n             transplantation\n\n          -  Unbalanced diabetes requiring, in the previous 4 months, intensive insulin therapy.\n\n          -  Central macular thickness greater than 350 \u00b5m\n\n          -  Visual acuity less than 20/32 measured using an ETDRS chart\n\n          -  Proliferative diabetic retinopathy associated with \"high risk factors\" (extensive\n             prepapillary neovessels and/or preretinal or prepapillary neovessels associated with\n             preretinal of intravitreal hemorrhage)\n\n          -  Macular edema due to causes other than diabetic retinopathy (venous occlusion,\n             uveitis) or occurring in  a context of vitreomacular traction\n\n          -  Already started PRPC\n\n          -  History of eye surgery or YAG laser capsulotomy performed during the preceding 6\n             months\n\n          -  Subjects under legal supervision or guardianship"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01766362", 
            "org_study_id": "Creuzot Innov 2010"
        }, 
        "intervention": {
            "arm_group_label": [
                "A session", 
                "Four sessions"
            ], 
            "intervention_name": "PRPC using Pascal laser", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 10, 2013", 
        "location": [
            {
                "contact": {
                    "email": "catherine.creuzot-garcher@chu-dijon.fr", 
                    "last_name": "Catherine CREUZOT-GARCHER", 
                    "phone": "3 80 29 51 73", 
                    "phone_ext": "+"
                }, 
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21000"
                    }, 
                    "name": "CHU Dijon"
                }, 
                "investigator": [
                    {
                        "last_name": "Catherine CREUZOT-GARCHER", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Alain BRON", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Laurent KODJIKIAN", 
                    "phone": "4 26 10 93 21", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69004"
                    }, 
                    "name": "CHU de la Croix Rousse"
                }, 
                "investigator": [
                    {
                        "last_name": "Laurent KODJIKIAN", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Zohra Nacera BOUSSAID", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Pascale MASSIN", 
                    "phone": "1 49 95 85 44", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75475"
                    }, 
                    "name": "H\u00f4pital Lariboisi\u00e8re"
                }, 
                "investigator": [
                    {
                        "last_name": "Pascale MASSIN", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Ali ERGINAY", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Zeynep VICTOR", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "S\u00e9bastien BRUNEAU", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "B\u00e9n\u00e9dicte DUPAS", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Julien PEROL", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients.", 
        "overall_contact": {
            "email": "catherine.creuzot-garcher@chu-dijon.fr", 
            "last_name": "Catherine CREUZOT-GARCHER", 
            "phone": "3 80 29 51 73", 
            "phone_ext": "+33"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Central macular thickness at 9 months after the start of PRPC using Pascal laser.", 
            "measure": "Macular thickness", 
            "time_frame": "9 months after the start of traitement"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01766362"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Universitaire Dijon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire Dijon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}